Introduction
Functional tRNAs carry a number of chemically modified nucleosides that are formed enzymatically after transcription, during the tRNA maturation process. To date, more than 90 different modifications have been identified in tRNAs from various organisms. 1 Among these post-transcriptional nucleoside modifications, N 1 -methyladenosine (m 1 A) is found at a highly conserved A 58 position in the TΨC loop of many tRNAs in the three domains of life (Bacteria, Archaea and Eukarya). This modification occurs infrequently in bacteria and, for instance, is absent in E. coli tRNAs. On the contrary, it is common in the tRNAs of most eukaryotes and archaea, and this modification seems to be essential for some organisms. Actually, in the yeast Saccharomyces cerevisiae, mutants defective in N 1 -methylation of A 58 are non-viable. 2 Likewise, in Thermus thermophilus, gene disruption studies have shown that m 1 A 58 modification is required for growth of this bacterium at high temperatures. 3 S-Adenosyl-L-methionine (AdoMet) dependent methyltransferases (MTases) are involved in a wide variety of biological processes involving methylation of nucleic acids, proteins, phospholipids and small molecules using the ubiquitous methyl donor AdoMet. Recently, two essential genes of S. cerevisiae, GCD10 and GCD14 (renamed TRM6 and TRM61), were identified to encode the two types of subunits of the yeast m 1 A 58 MTase. 4 The recombinant enzyme behaves as an α 2 β 2 heterotetramer, Trm61p being responsible for AdoMet binding and presumably catalysis of the methyl transfer reaction, 2 whereas both types of subunits are essential for tRNA-binding. 5 Indeed, the purified recombinant Trm61p subunit, which binds AdoMet, cannot bind tRNA in vitro in the absence of Trm6p. 2 Interestingly, Trm61p was found to be closely related to a group of prokaryotic proteins which share not only the same AdoMet-binding site but also other highly conserved motifs. Therefore, the corresponding prokaryotic proteins were presumed to act as m 1 A 58 MTases. 6 This hypothesis was demonstrated experimentally for the bacterial orthologs in Thermus thermophilus and Mycobacterium tuberculosis and for the archaeal ortholog in Pyrococcus abyssi. 3, [7] [8] [9] These proteins are α 4 homotetramers of Trm61p-like proteins, hereafter called TrmI. Interestingly, orthologs of the Trm6p protein could only be found in eukaryotes. It was shown that Trm6p, despite the absence of the characteristic MTases motifs, is structurally and evolutionary related to Trm61p suggesting that the eukaryotic m 1 A 58 MTases evolved by gene duplication and speciation to form a heteromultimeric protein, whereas their prokaryotic orthologs remained homomultimers. 6 Despite the low level of sequence similarity between the various families of AdoMetMTases, most of them contain a structurally highly conserved catalytic AdoMet-binding domain organized in a Rossman-like fold (For a review see 10 ). Only one crystal structure of an m 1 A 58 tRNA MTase has been reported to date, that of the M. tuberculosis Rv2118c protein (mycoTrmI) in complex with S-adenosyl-L-methionine. 7 It shows that the catalytic C-terminal domain is very similar to that of other AdoMet-dependent MTases whereas the Nterminal domain which is mainly composed of β-sheets is not found in other MTases of known structure.
In the present work, we have first solved the crystal structure of the m 1 A 58 tRNA MTase from T. thermophilus (thTrmI) at 1.7 Å resolution in complex with S-Adenosyl-Lhomocysteine (AdoHcy), the product after methyl transfer. We then focused our attention on the tRNA-binding properties of thTrmI using several biophysical techniques, including electrospray ionization mass spectrometry (ESI-MS), site-directed mutagenesis, steady-state kinetic assays, fluorescence spectroscopy and molecular docking. ESI-MS has demonstrated its particular suitability for the investigation of noncovalent complexes. [11] [12] [13] More particularly, so-called noncovalent ESI-MS has been extensively used to characterize supramolecular assemblies involving oligonucleotides in interaction with drugs and proteins (For reviews see [14] [15] [16] [17] ). As protein:RNA systems are partly driven by electrostatic-based interactions which are strongly enhanced in the gas phase, ESI-MS is well suited for their characterization. 18, 19 Indeed, numerous studies of protein-RNA complexes have revealed a strong agreement between mass spectrometric gas-phase measurements and results obtained by solution phase
techniques. [20] [21] [22] [23] [24] In our work, we used noncovalent ESI-MS: i) to unambiguously assess the oligomerisation state of thTrmI ; ii) to monitor the thTrmI oligomerisation state upon tRNA binding and iii) to determine the stoichiometry of the thTrmI-tRNA complexes. In addition, a mutagenesis study was performed to identify residues potentially crucial for the methylation reaction. We thus showed that the universally conserved D170 residue, together with two conserved aromatic residues, Y78 and Y194, which line the catalytic pocket are key residues for the enzymatic catalysis. Actually, D170A and Y78A variants are severely altered in their catalytic efficiency. Finally, we have used molecular docking to position a N 9 -methyladenine in the active site of TrmI to further investigate the possible role of these residues.
Results and Discussion

Structure determination of T. thermophilus TrmI
Production and purification of T. thermophilus TrmI (thTrmI) have been described by Droogmans and coworkers. 3 However, the recombinant His 6 -tagged protein exhibited a low solubility (< 0.5 mg/mL) unless high salt concentrations were added (0.2 M imidazole-HCl and 0.5 M KCl). This was a serious issue for crystallization assays, in which precipitating solutions must be added to concentrated protein. In order to improve solubility, the Nterminal His 6 -tag of thTrmI was cleaved with thrombin. Indeed, after His 6 -tag removal, thTrmI became highly soluble (> 10 mg/mL), even at moderate ionic strengths (150 mM). This type of behaviour has already been reported for some His-tagged proteins. 25 We then carried out crystallization assays on the complex between thTrmI, AdoHcy and E. coli tRNA i
Met
. The latter tRNA was selected because it is devoid of modification on A 58 and is a substrate of the T. thermophilus enzyme (see paragraph on steady-state kynetic assays).
Although the tRNA was present in all crystallization conditions, crystals only contained the free thTrmI protein in complex with AdoHcy. identical and 13% similar residues with mycoTrmI. The model was then refined to 1.7 Å, to a final R free factor of 20.9% (Table 1 ). The last four residues at the N-terminus were too poorly ordered to be included, and therefore the final model consisted of 251 residues per monomer.
The asymmetric unit contained a dimer of thTrmI. However, the symmetry-related subunits interact extensively leading to a tetrameric organization of thTrmI (Figure 1(b) ).
Overall structure of thTrmI
The thTrmI monomer is composed of two distinct domains connected by an extended linker containing a short α-helix (helix 2, Figure 1(a) ). The large C-terminal domain (residues 63-255) adopts a typical class I MTase fold which consists of a central seven-stranded β sheet (β 1 to β 6 and β 8 - Figure 1 (a)) flanked by α helices on both sides (α A to α E - Figure 1(a) ).
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The first five strands of the β sheet (β 1 to β 5 on Figure 1 (a)) are parallel whereas the last two (β 6 to β 8 ) are antiparallel. The C-terminal domain contains the AdoMet binding site and the catalytic pocket. The smaller N-terminal domain (residues 5-62) is largely a β structure composed of six β-strands (β A to β F Figure 1 (a)) and one small α helix (α 1 ).
The thTrmI tetramer is organised as a dimer of tight dimers. Two monomers interact via their extended β 6 strands which form a cross-subunit, antiparallel β-sheet (Figure 1(b) , pale and dark blue). This dimer is further stabilized by ionic interactions between helices α 2 and α 3 from each subunit (Figure 1(b) ). A pair of β 6 strands from each dimer packs on the related β 6 strands of the other dimer to form a central anti-parallel β-sheet structure. The tetramer interaction is limited to this β-sheet region and stabilized by both ionic and hydrophobic interactions, mainly a salt bridge between E220 and R224, hydrophobic interactions between W226 and F245, and between H234 and F237 from one dimer to H242 from the other dimer.
The salt bridge and the hydrophobic interactions between W226 and F245 have been also observed on the mycoTrmI structure 7 and involve conserved residues.
In the tight dimer found in the asymmetric unit, the two cofactor-binding sites are occupied by AdoHcy molecules in identical conformations, similar to that of AdoMet in the M. tuberculosis TrmI structure. The binding cleft is formed by residues belonging to conserved motifs, named I, II, III, IV, (Figures 1(c) , 1(d) and 7(a)). 27 The adenine ring of the AdoHcy moiety is bound by motifs II, III, and IV via water-mediated hydrogen bonds between the exocyclic amino group and residues E155 and E173, and between the N 7 position of the adenine and the backbone amide of E173 (Figure 1(c) ). Adenine binding is also reinforced by hydrophobic contacts between its aromatic ring and residues L171, V177, K153, L154, Y124, A126 and A100. The ribose moiety of AdoHcy is bound by motif II, essentially by hydrogen bonds involving the 2' and 3' hydroxyl groups and residues E125
and H130. The amino-acid part of the cofactor is mainly bound by motif I. Interestingly, an aspartate side chain that could be involved in the methylation reaction, the carboxylate chain of D170 from motif IV, participates to a direct polar interaction with the ammonium group of AdoHcy. The GXGXGG pattern of motif I binds to the amine and the carboxylate through a tight network of water-mediated hydrogen bonds involving the backbone (Figure 1(c) ).
Comparison with mycoTrmI structure and tRNA recogition
Globally, the overall structure of thTrmI closely resembles that of mycoTrmI.
Superimposition of T. thermophilus and M. tuberculosis
TrmI structures gives a root mean square deviation of 4.47 Å for Cα, the largest variation occurring in the β-strands (β 6 , β 7 , β 8 )
that protrude out of the structure. When comparing the active sites more accurately, that of mycoTrmI is narrower by about 1 Å than that of thTrmI. Moreover, the protruding R249 in mycoTrmI makes like a supplementary step at the exit of the pocket that does not exist in thTrmI as R249 is replaced by a shorter side chain residue (V240). As a consequence, the accessible surface of Y78 is twice larger in thTrmI than that of Y84 in mycoTrmI. All these features seem to make the methyl donor less easily accessible in mycoTrmI. Overall, in both structures, the adenine should enter deeply in the binding cleft to have access to the methyl donor therefore implicating a major deformation of the phosphodiester backbone around A 58 .
It is also highly interesting to compare electrostatic potentials of their molecular surfaces The fact that, in eukaryotes, the enzyme has evolved from an α 4 homotetramer to an α 2 β 2 heterotetramer is compatible with a two tRNA per TrmI tetramer stoichiometry, one tRNA being expected to interact with an αβ subsystem.
thTrmI is a tetramer and binds up to two tRNA molecules as a tetramer.
Close inspection of the crystal structures of thTrmI and mycoTrmI 7 revealed that the tetramers are formed by two pairs of extensively interacting subunits stabilized by relatively small numbers of contacts between the two dimers. Given the architecture of TrmI, it was of interest to investigate the oligomerization state of thTrmI alone and upon tRNA binding, and to determine the binding stoichiometry of the thTrmI-tRNA complexes. Previously reported gel filtration experiments have indicated that both mycoTrmI and thTrmI should form tetramer in solution. 3, 9 However, in the case of thTrmI, due to an inherent limited precision of this technique, it is difficult to unambiguously state whether the protein is tetrameric or pentameric. 3 In this study, we used ESI-MS, which has been proven to be a valuable technique for the determination of oligomerization states of noncovalent assemblies [28] [29] [30] [31] to first confirm the oligomerization state of thTrmI. which is in favour of non-cooperative tRNA binding system and further suggests the presence of two independent tRNA binding sites. 32 The same experiments were also carried out in presence of AdoHcy (data not shown) and no effect either on the binding stoichiometry of the complex or on the binding affinity of the tRNA for thTrmI was observed.
As ESI-MS detects species in the gas phase of the mass spectrometer, control experiments are always needed to ensure that mass spectra faithfully reflect the behaviour in solution. 33 Thus, since electrostatic interactions are sensitive to the ionic strength of the medium, 34, 35 experiments were carried out at different ammonium bicarbonate concentrations ( Figure 5 ).
Decreasing the ammonium bicarbonate concentration from 200 mM to 100 mM displaces the equilibrium towards the formation of (thTrmI) 4 :(tRNA) 1 and (TrmI) 4 :(tRNA) 2 complexes ( Figure 5(a-b) ). However, the signal intensities were dramatically lower when 100 mM ammonium bicarbonate was used rather than 200 mM buffer, mainly because of protein precipitation. Therefore, no ESI-MS analysis could be performed at buffer concentrations lower than 100 mM. While both (thTrmI) 4 :(tRNA) 1 and (thTrmI) 4 :(tRNA) 2 complexes are favoured at low ionic strengths, the use of higher salt concentrations destabilizes these assemblies ( Figure 5(c-d) ), leading even to a complete dissociation of thTrmI:tRNA complexes into thTrmI tetramer at 1250 mM ammonium bicarbonate ( Figure 5(d) ). The fact that mass spectra do reflect expected changes induced by modification of the solution conditions is a further evidence that allows us to definitely rule out the possibility that the TrmI-tRNA complexes result from an artefact of the technique. Moreover, as described in other publications, 22, 36 an additional ESI-MS control experiment was performed in strictly identical experimental and operating conditions with a non-substrate RNA as a negative control. The absence of any thTrmI-control RNA complex on ESI mass spectra even in presence of a five-fold molar excess of control RNA ( Figure 6 ) indicates that the gas phase detection of the TrmI-tRNA complexes arises from a specific recognition in solution and not from any gas phase artefact.
In conclusion, noncovalent ESI-MS results clearly support that thTrmI remains tetrameric upon tRNA binding and that thTrmI binds up to two molecules of tRNA.
The D170A and Y78A variants of thTrmI are severely altered in their catalytic efficiency.
On the basis of multiple sequence alignments of the TrmI family members (Figure 7(a) ) and on the comparison of the crystallographic structures of TrmI from M. tuberculosis 7 and T.
thermophilus, we chose to mutate three conserved residues, D170, Y194 and Y78 in order to study their involvement in adenosine binding and/or in catalysis. Figure 7 (b) presents the thTrmI residues that are conserved or semi-conserved in the catalytic pocket, except the conserved residues that bind to AdoMet since their role in the catalysis mechanism is known.
Yet, the universally conserved AdoMet-binding D170 was selected as it forms the back of the catalytic pocket and may also bind the adenine 58 ring of the tRNA substrate ( Figure 7(b) ).
Y194 and Y78 were mutated because they respectively form the left side and the floor of the adenosine-binding pocket in the 3D structure ( Figure 7(b) ) and are conserved as aromatic residues among m 1 A 58 tRNA MTases, belonging respectively to motifs V and X ( Figure   7 (a)). Therefore, these aromatic residues could be involved in the stabilization of the target adenine that needs to be flipped out of the tRNA structure to be methylated. P196 that is involved in making the shape of the catalytic cavity was not selected for mutation, because in M. tuberculosis, it is naturally replaced by an alanine. Therefore, we individually mutated Y78, D170 and Y194 to alanines. We expressed and purified the variant proteins as described in Materials and Methods section. We then determined the kinetic and RNA-binding parameters for wild-type and variant proteins (Table 2) .
First, we investigated whether the mutations altered tRNA binding by the enzyme.
Interaction with tRNA induces a quenching of the intrinsic tryptophan fluorescence of the protein of about 40 %. We therefore used fluorimetric titrations to determine the apparent dissociation constant between thTrmI variants and tRNA i Met ( Table 2 ). All mutants showed quite unchanged dissociation constants (K d about 15 ± 3 nM), thereby indicating that they retained a native folding and similar RNA binding ability compared to the wild-type enzyme.
We then analysed their catalytic properties by determining their kinetic parameters k cat and K M for both AdoMet and tRNA substrates. The overall results are summarized in Table 2 .
Interestingly, all mutants retain some catalytic activity, but are altered to various extents, Table 2 ). The K M value for AdoMet is increased suggesting that this residue is involved in cofactor binding. Yet, in the crystal structure, it is not involved in a direct interaction with AdoHcy in contrast to D170. The mutation of Y194 to an alanine probably slightly destabilizes the catalytic pocket or indirectly weakens AdoMet binding. In conclusion, D170A is the variant that is most largely altered in its catalytic efficiency followed by Y78A and then Y194A. And, therefore, D170, Y78 and Y194 are key residues in the catalytic mechanism.
The substrate adenine snugly fits in the active site pocket of thTrmI.
To to drive the docking process. An AIR is defined as an ambiguous distance between all residues shown to be involved in the interaction. Ambiguous intermolecular distance restraints were applied between D170, Y194, Y78 and the AdoMet cofactor on the one hand, and the N 9 -methyladenine, on the other hand. A distance restraint between the N 1 atom of N 9 -methyladenine and the methyl of AdoMet was also added. The model resulting from the docking with thTrmI is presented in Figure 8 (a) and shows that the N 9 -methyladenine fits snugly in the cavity where methylation takes place. The same result was obtained for mycoTrmI (data not shown). Moreover, the methyl group introduced to substitute the ribose is pointing above Y78 (Figure 8(b) ) enabling us to add a ribose without steric hindrance.
Therefore, Y78 is likely to strongly interact with the ribose of the adenosine 58 probably participating to stabilization of the flipped-out conformation. The distance between the N 9 -methyladenine N 1 and the AdoMet methyl group is 2.3 Å. This corresponds to a distance between the N 9 -methyladenine N 1 and the AdoMet sulphur atom of 4.1 Å. This is in keeping with distances observed in co-crystal structures of other endocyclic purine N-MTases (distances between 3.6 Å and 4.5 Å). 38 The docked model of the N 9 -methyladenine ring suggests a binding mode involving essentially Van der Waals interactions with Y194, and a polar contact between the exocyclic amino group of the purine and the carboxylate of D170 (Figure 8(b) ). Therefore, the side chain of D170 could act as a bidentate ligand binding the amino terminal moiety of AdoMet and the N 6 exocyclic amino group of the adenine ring substrate. Thus, the sulphur-methyl bond of AdoMet is almost coplanar with the N 9 -methyladenine ring and is pointing to the same direction as the N 1 lone-pair orbital, which can be of significant importance for the chemical mechanism. We thus propose that D170 could minimize the transition state energy by positioning both the AdoMet and the target base in an optimal orientation for the methylation reaction. D170 could also deprotonate the N 6 group to activate the N 1 lone-pair orbital in order to attack the methyl group of AdoMet and to generate the exocyclic imino tautomer of N 1 -methyladenosine as the initial product. The nucleophilic attack leads to the m 1 A basic form which has to be subsequently protonated to
give the m 1 A cationic form, stable at physiological pH (pKa = 9.3). 39 As the deprotonation of N 6 of m 1 A is easier than the deprotonation of N 6 of the non-methylated adenine ring (pKa = 16.7), 40 it seems more reasonable that the deprotonation and the nucleophilic attack occur in the same elementary step. The model perfectly situates D170 to serve that role, which is most definitely consistent with the kinetic results.
The chemical mechanism of adenine N 1 methylation of RNA had not yet been investigated in contrast to the N 1 methylation of guanine. 41 In the case of m 1 G RNA methyltransferase (TrmD), 41 an aspartate residue was shown to be involved in the deprotonation step of N 1 of guanine. The two processes are likely to be different, as under physiological conditions, the N 1 of guanine is protonated but that of adenine is not. DNA methyltransferases have been extensively studied, but the m 1 A modification is not encountered in DNA. The methylation of the N 6 position of adenine has been investigated in DNA (for structural studies see [42] [43] [44] ) and more recently in rRNA. 45, 46 Interestingly, the main catalytic residue in m 6 which is proposed to stabilize the cationic transition state by cation-π interaction. 49, 50 And the second one is the aromatic residue Y/F/W of motif VIII, which stabilizes the flipped base outside the DNA helix. 49, 50 These aromatic residues are conserved in motifs IV and VIII in m 1 A tRNA MTases (Figure 7(a) , symbol o), but they are not part of the catalytic pocket in the TrmI structure. Strikingly, two other aromatic residues, i.e. Y78 and Y194, are located in the active site cavity of thTrmI (Figure 7(b) ) at relative positions with respect to the AdoMet cofactor similar to those of the aromatic residues listed above for DNA MTases. These residues are also conserved as aromatic residues among m 1 A 58 tRNA MTases and belong respectively to motifs X and V (Figure 7(a) ). The noticeable structural similarity between the catalytic pocket of m 1 A tRNA MTases and m 6 A DNA MTases suggests a similar role in catalysis for these residues. Y78 is thus the most probable candidate for the stabilization of the flipped-out adenosine given its position in the catalytic pocket and the dramatic decrease of k cat of the Y78A mutant. Then, Y194 could act as a cation-π catalyst to stabilize a cationic transition state. These roles are also in agreement with our docking results.
Coordinates and structure factors for T. thermophilus TrmI protein in complex with AdoHcy have been deposited at the Protein Data Bank with accession code 2PWY.
Materials and Methods
Expression and purification of thTrmI for structural studies
Recombinant T. thermophilus TrmI protein (255 residues) was overexpressed and purified as previously described. 3 The N-terminal His 6 -tag was removed by thrombin cleavage concentrated to 8-10 mg/mL using Amicon Ultra (Millipore) and stored at 4 °C.
Crystallization and crystal structure determination
Crystallization was performed at 19 °C using the sitting drop vapour diffusion method.
Protein samples were prepared at 3 mg/mL in 50 mM Tris-HCl buffer (pH 8.0) containing 100 mM KCl, 2 mM AdoHcy and 1 equivalent of tRNA i
Met
. Drops of 1 µL were prepared by using a Cybi-Disk robot system that mixes equal volume of protein and reservoir solutions. All crystallographic calculations were performed using the CCP4 suite version 6 51 as implemented in the graphical user interface. 52 X-ray diffraction data were processed using MOSFLM 53 and scaled with SCALA. 54 The structure of thTrmI was solved by molecular replacement using the program PHASER 26 and the structure of m 1 A 58 tRNA MTase from M.
tuberculosis (PDB entry code 1I9G) as a model. In the model, non-conserved residues were truncated to alanine. Model building of thTrmI was first performed with ARP/wARP 55 using the warpNtrace automated procedure. Restrained refinements of the structure were performed with the program REFMAC5. 56 Model and maps visualisations for manual reconstruction were performed with the program COOT. 57 Solvent molecules were automatically added using ARP waters module implemented in REFMAC5. In the last stages of refinement, TLS parameters were refined 58 using one group for each domain of the protein, i.e. the large Cterminal domain and the small N-terminal domain.
We computed the electrostatic surface potential using APBS Tools, an interface for performing APBS electrostatics calculation 59 from within PyMOL (http://www.pymol.org).
Expression and purification of tRNA i Met
The E. coli tRNA i Met was overexpressed from plasmid pBSTtRNA f Met in E. coli JM101TR using a protocol derived from that of Meinnel and Blanquet. 60 mM to 1250 mM were tested. A concentration of 200 mM ammonium bicarbonate was chosen as the best compromise to provide good quality ESI mass-spectra without extensive thTrmI:tRNA complexes dissociation (which takes place at high ionic strengths) or protein aggregation (occurring at low ionic strengths). Thus, this buffer concentration was used to study both thTrmI oligomerization state and its tRNA-binding properties. All experiments were carried out at 20 µM thTrmI (tetramer concentration) whereas E. coli tRNA i Met concentration (molecular weight MW = 24888 Da) was increased up to 200 µM for titration experiments. To study the influence of AdoHcy on the thTrmI-tRNA complexation equilibrium, thTrmI and AdoHcy, both at 20 µM (tetramer concentration), were incubated in the ammonium bicarbonate buffer in presence or in absence of tRNA (30 µM). Finally, a non-substrate control RNA of 59 nucleotides (MW = 19255 Da) was also used in a five-fold molar excess relative to the thTrmI tetramer concentration in order to investigate the specificity of the thTrmI-tRNA interactions. All solutions were incubated for 15 minutes at room temperature before analysis under non-denaturing conditions.
Non-denaturing agarose gel electrophoresis
Samples were prepared by mixing constant amount of E. coli tRNA i Met (4 µg) with increasing amounts of thTrmI protein (from 0 to 1 molar equivalent of thTrmI tetramer) in loading buffer (Tris-HCl pH 8.0 50 mM, KCl 100 mM, glycerol 18 % (v/v)). Samples were kept at 4 °C for 12 hours and loaded on a 2 % (w/v) agarose gel. Migration was performed for one hour in Tris-Acetate buffer pH 8.0 at 4 °C under an electric field of 100 V. Bands were visualized by UV shadowing.
Site-directed Mutagenesis
Alanine site-directed mutagenesis was carried out using the Quickchange kit and protocol (Stratagene). All oligonucleotides for mutagenesis were designed to have appropriate pairing stability (fusion temperature near 80 °C) and were between 27 to 32 nt long. All mutant genes were fully sequenced and contained only the desired substitutions.
Expression and purification of wild-type and mutant thTrmI proteins for kinetic studies
The wild type and mutant proteins were overexpressed and purified as for structural studies except that the thrombin cleavage was omitted. Protein concentrations were evaluated with the Bradford method. The proteins were then diluted in 50 mM Tris-HCl pH 8.0 to a final concentration of 0.25 mg/mL and stored at 4 °C.
Fluorescence titrations of thTrmI by tRNA i Met
Fluorescence measurements were performed at 20 °C on a JASCO spectrofluorimeter.
Excitation and emission wavelengths were 280 nm and 343 nm respectively. The excitation and emission bandwidths were 5 nm and 10 nm respectively. (1)
where I 0 , Fluorescence intensity without tRNA; I, fluorescence intensity at a given concentration of tRNA; I ∞ , fluorescence intensity at the plateau; n, number of tRNA binding sites on the protein; N t , total concentration of protein; L t , total concentration of tRNA.
Confidence limits on the parameters were estimated by Monte-Carlo sampling. 
Molecular Docking
Docking of the N 9 -methyladenine ring into the active site of TrmI was performed using HADDOCK restraints can be applied between residues and not only between atoms. The protein structure used for the docking was the tetrameric T. thermophilus TrmI crystal structure in which the AdoHcy ligand was replaced with the AdoMet methyl donor. A 2 Å distance was used to define ambiguous restraints (AIRs) that were applied between the adenine and a set of neighbours composed of AdoMet cofactor and thTrmI residues identified by mutagenesis (i.e.
Y78, D170 and Y194). One unambiguous restraint set to 2 Å was applied between the atoms that react in the methyl transfer reaction, i. thermophilus structure except the conserved residues that bind AdoMet. AdoMet was modeled from AdoHcy by adding a methyl group on the sulphur atom, the methyl is positionned by the sulfonium chirality. Y78, Y194 and D170 are indicated as red sticks. 
